— Know what they know.
Not Investment Advice
Also trades as: 0A23.L (LSE) · $vol 0M

PHR NYSE

Phreesia, Inc.
1W: -7.1% 1M: -15.9% 3M: +13.9% YTD: -36.8% 1Y: -59.3% 3Y: -66.0% 5Y: -83.5%
$10.31
+0.14 (+1.38%)
 
Weekly Expected Move ±6.7%
$9 $10 $10 $11 $12
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 41 · $637.3M mcap · 49M float · 2.23% daily turnover · Short 62% of daily vol
Smart Money Score
Bullish 75
Insider+$28.8M
Congress
ETF Holdings
Key Statistics
Market Cap$637.3M
52W Range7.77-25.29
Volume526,641
Avg Volume1,099,150
Beta0.86
Dividend
Analyst Ratings
18 Buy 8 Hold 0 Sell
Consensus Buy
Company Info
CEOChaim Indig
Employees1,789
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2019-07-18
1521 Concord Pike
Wilmington, DE 19803
US
888 654 7473
About Phreesia, Inc.

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

Recent Insider Trades

NameTypeSharesPriceDate
Linetsky David A-Award 192,000 2026-09-01
Linetsky David A-Award 10,000 2026-09-01
VanDuyn Amy Beth A-Award 88,000 2026-09-01
Roberts Evan A-Award 192,000 2026-09-01
Indig Chaim A-Award 500,000 2026-09-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms